Molecular Diagnosis of Cancer Methods and Protocols
The growing tide of novel therapeutics that target molecules within a specific individual's cancer cells-over 300 such agents are currently in phase I or II clinical trials-makes it essential to employ appropriate diagnostic methods and approaches when selecting patients for treatment. In Molec...
| Other Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Totowa, NJ
Humana Press
2004, 2004
|
| Edition: | 2nd ed. 2004 |
| Series: | Methods in Molecular Medicine
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer Protocols Archive 1981-2004 - Collection details see MPG.ReNa |
Table of Contents:
- Prognostic and Predictive Factors
- Assessment of Predictive Values of Tumor Markers
- Quality Assurance of Predictive Markers in Breast Cancer
- Extraction of Nucleic Acid Templates
- Microdissection and Extraction of DNA From Archival Tissue
- Fluorescence In Situ Hybridization
- HER2 FISH in Breast Cancer
- Fluorescence In Situ Hybridization for BCR-ABL
- UroVysion™ Multiprobe FISH in Urinary Cytology
- Chromogenic In Situ Hybridization in Tumor Pathology
- Comparative Genomic Hybridization and Fluorescence In Situ Hybridization in Chronic Lymphocytic Leukemia
- Molecular Characterization of Human Papillomaviruses by PCR and In Situ Hybridization
- A Nested RT-PCR Assay to Detect BCR/abl
- TP53 Mutation Detection by SSCP and Sequencing
- PCR Diagnosis of T-Cell Lymphoma in Paraffin-Embedded Bone Marrow Biopsies
- Circulating DNA Analysis
- Microsatellite Instability
- Diagnostic and Prognostic Significance of the Methylation Status of Myf-3 in Lymphoproliferative Disorders
- Quantitative Analysis of PRAME for Detection of Minimal Residual Disease in Leukemia
- Determination of Cyclin D1 Expression by Quantitative Real-Time, Reverse-Transcriptase Polymerase Chain Reaction
- Detection of Telomerase hTERT Gene Expression and Its Splice Variants by RT-PCR
- Detection of Telomerase Enzyme Activity by TRAP Assay
- Identification of TP53 Mutations in Human Cancers Using Oligonucleotide Microarrays
- Detection of K-ras Mutations by a Microelectronic DNA Chip
- Microarray-Based CGH in Cancer
- Tissue Microarrays